The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial
Open accessAbstract
We read with great interest the recent article by Schächinger et al.1 showing improved 1 year clinical outcomes in patients with acute myocardial infarction receiving intracoronary administration of bone marrow-derived progenitors cells (BMCs) after successful reperfusion therapy. The authors attribute the improved clinical outcomes in the treatment group to the recovery of global left ventricular contractile function within 4 months, as recently reported in the same patient population.2 However, we believe that factors other than administration of BMCs may have influenced left ventricular ejection fraction (LVEF) recovery and, hence, clinical outcomes in their study. First, we can suppose that spontaneous LVEF recovery was already occurring in both groups before BMCs or placebo administration. Indeed, baseline LVEF was 46.7 ± 10 and 47.5 ± 10% in controls and BMC-treated patients, respectively—values higher than that used as a threshold for patient inclusion in the study (≤45%). This spontaneous recovery may be explained by the mean delay between enrolment and baseline LVEF measurement (4.3 ± 1.3 days). Secondly, and more importantly, two major determinants of LVEF recovery—time-to-reperfusion and infarct location—are possible confounders in this study. According to Sheiban et al.,3 LVEF recovery is usually observed after primary angioplasty if coronary flow is restored ≤4 h from symptom onset, whereas no significant improvement occurs afterwards. This time “window” may be even narrower in anterior infarctions. Indeed, we have observed no significant recovery in LVEF after primary angioplasty despite an average shorter time-to- reperfusion (2.5 ± 1.4 h) when only anterior myocardial infarctions were considered.4 In the REPAIR-AMI study, however, the authors analysed anterior and inferior infarctions together, despite the fact that these two infarct locations differ in terms of acute left ventricular impairment severity, LVEF recovery and clinical outcome after reperfusion therapy.5,6 In BMC-treated patients, anterior infarctions were less represented (64 vs. 76%), which may explain the small difference in LVEF recovery between the placebo and treated groups (3.0 ± 6.5 vs. 5.5 ± 7.3%), and in clinical outcomes.1,2 Moreover, mean reperfusion time was ≥7 h, an interval usually not associated with LVEF improvement, particularly in anterior infarctions.3,4 The combination of different times to treatment and infarct locations may have a major influence on LVEF recovery and long-term event rate. It is surprising that these two critical factors were not taken into account among the variety of covariates considered by the authors. Thus, we believe that the LVEF changes and clinical outcomes should be re-analysed after adjustment for infarct location and time-to-reperfusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N. M., & Itescu, S. (2001) · Nature Medicine · doi:10.1038/86498 · Cited by 2,540
Assmus, B., Schächinger, V., Teupe, C., Britten, M., Lehmann, R., Döbert, N., Grünwald, F., Aicher, A., Urbich, C., Martin, H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000043246.74879.cd · Cited by 2,201
Wollert, K. C., Meyer, G. P., Lotz, J., Ringes Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16626-9 · Cited by 2,191
Strauer, B. E., Brehm, M., Zeus, T., Köstering, M., Hernandez, A., Sorg, R. V., Kögler, G., & Wernet, P. (2002) · Circulation · doi:10.1161/01.cir.0000034046.87607.1c · Cited by 2,067
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060186 · Cited by 1,890
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction
Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., Endresen, K., Ilebekk, A., Mangschau, A., Fjeld, J. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055706 · Cited by 1,310
Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., Kalantzi, M., Herbots, L., Sinnaeve, P., Dens, J., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67861-0 · Cited by 1,294
Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia
Kawamoto, A., Gwon, H.-C., Iwaguro, H., Yamaguchi, J.-I., Uchida, S., Masuda, H., Silver, M., Ma, H., Kearney, M., Isner, J. M., et al. (2001) · Circulation · doi:10.1161/01.cir.103.5.634 · Cited by 1,220
Cited by
Makkar, R. R., Smith, R. R., Cheng, K., Malliaras, K., Thomson, L. E., Berman, D., Czer, L. S., Marbán, L., Mendizabal, A., Johnston, P. V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60195-0 · Cited by 1,422
Stem-cell therapy for cardiac disease
Segers, V. F. M., & Lee, R. T. (2008) · Nature · doi:10.1038/nature06800 · Cited by 1,179
Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation
Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., Hu, Q., Feigenbaum, G. S., Margitich, I. S., Mazhari, R., Boyle, A. J., Zambrano, J. P., Rodriguez, J. E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.222703 · Cited by 715
Lipinski, M. J., Biondi-Zoccai, G. G. L., Abbate, A., Khianey, R., Sheiban, I., Bartunek, J., Vanderheyden, M., Kim, H.-S., Kang, H.-J., Strauer, B. E., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.041 · Cited by 509
Tendera, M., Wojakowski, W., Rużyłło, W., Chojnowska, L., Kępka, C., Tracz, W., Musiałek, P., Piwowarska, W., Nessler, J., Buszman, P., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp073 · Cited by 473
Metadata
- Authors
- Marenzi, G., & Bartorelli, A. L.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-19
- Volume
- 28
- Issue
- 17
- Pages
- 2172-2173
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2146159580
- Cited by
- 487
- References
- 23
- FWCI
- 30.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehm257
- The paper
- Marenzi, G., & Bartorelli, A. L. (2007). Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehm257
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.